Oracle Health Sciences has expanded its Oracle Argus Cloud Service: stakes and opportunities.

It is official since Jun, 24, 2013 Oracle has decided to anticipate with this new approach. The goal is to help health sciences organizations meet increasingly stringent regulatory requirements
and ensure product safety while optimizing IT return on investment.

 This also means enable global monitoring and deliver new insight into adverse events and pharmacovigilance programs.

In addition, the integration of Oracle Argus Japan, now ‘’creates a single global database for safety data, including data from Japan, and enables a unified workflow and reporting environment designed to improve process efficiency and expand visibility’’. ‘’Oracle Argus Cloud Service also includes expanded analytical and reporting capabilities that help to integrate safety and risk management.

 “Oracle Argus Cloud Service delivers extended value to health sciences organizations with the addition of Oracle Argus Japan, Oracle Argus Analytics and Oracle Argus Insight. Trial sponsors and contract research organizations can manage their end-to-end safety and pharmacovigilance programs with a leading solution suite while benefitting from a cloud-based delivery model that helps accelerate time to value, reduce risk, cut total cost of IT ownership and that provides unprecedented performance and scalability.” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences.

About Oracle Health Sciences

At Oracle, we believe that a more predictive, preventive, personalized and participatory system will help improve human health. We can help accelerate this journey to personalized medicine through technology, data and insights. Oracle’s solutions support industry initiatives to improve care quality and outcomes, reduce costs, and speed time to market for new treatments, therapies and devices.